Chemotherapy can save lives, however for a lot of most cancers sufferers, it leaves behind a painful legacy: broken nerves that burn, tingle or go numb. Now, researchers report {that a} psychedelic compound might defend these nerves — not via its mind-bending results, however by serving to neurons preserve their inner energy provides transferring.
A brand new mouse examine, revealed Thursday (Sept. 3) within the journal Science, means that psilocybin, the psychedelic compound in “magic mushrooms,” might assist stop this painful and generally everlasting aspect impact of chemotherapy, referred to as chemotherapy-induced peripheral neuropathy (CIPN).
In experiments in mice, psilocybin prevented nerve harm from CIPN that may trigger ache, numbness and heightened sensitivity to chilly and contact. Two doses of the drug given previous to chemotherapy garnered safety that continued via as many as six rounds of the most cancers therapy, based on the examine.
Newest Movies FromReside Science
CIPN impacts roughly one-third to one-half of individuals receiving sure chemotherapies, mentioned Dr. Thomas Strouse, a professor of medical psychiatry and a neuropathy researcher at UCLA who was not concerned within the examine. In extreme instances, the neuropathy can drive docs to cut back or cease chemotherapy. It could additionally contribute to mobility issues, which increase the danger of falls and fractures.
“It is a massive deal, massive downside,” Strouse mentioned. Researchers have been trying to find a technique to stop it for a very long time, he added.
Retaining nerve cells fueled
Initially, the researchers weren’t on the lookout for a neuropathy therapy, mentioned examine co-author Dr. Moran Amit, a most cancers surgeon and researcher at The College of Texas MD Anderson Most cancers Middle. His workforce was investigating whether or not compounds that promote neuroplasticity — the nervous system’s capacity to alter and adapt — would possibly defend nerves and enhance present most cancers remedies.
After testing a number of psychedelic compounds, they “very early on centered on psilocybin as a result of this was the best one” for relieving neuropathy signs, Amit informed Reside Science. The psychedelic has been explored as a therapy for psychiatric disorders such as depression, wherein it would promote “hyperconnectivity” between sure mind areas.
Get the world’s most fascinating discoveries delivered straight to your inbox.
Within the new examine, safety towards CIPN emerged as an surprising impact of the drug.
To analyze how that safety labored, the researchers studied mice handled with cisplatin, a chemotherapy drug known to frequently cause neuropathy. Two doses of psilocybin — given 9 days and two days earlier than the primary chemotherapy session, respectively — utterly prevented the mice from growing hypersensitivity, and it additionally decreased chilly sensitivity and preserved nerve endings within the pores and skin.
The workforce then ran experiments utilizing human sensory neurons and peripheral nerves that had been eliminated throughout surgical procedure. These analyses pointed to a potential rationalization: a course of known as mitochondrial trafficking.
Mitochondria generate the vitality that cells want, however neurons current an uncommon logistical problem. Some peripheral nerves prolong over huge distances, so their mitochondria should be transported alongside structural tracks, known as microtubules, to succeed in far-flung nerve endings. That in itself is an energy-intensive course of.
Amit in contrast these microtubules to a railroad system: Chemotherapy can harm each the mitochondria themselves and the tracks they journey alongside.
In additional experiments with human neurons, the workforce discovered that cisplatin depleted mitochondria and ATP (adenosine triphosphate) — cells’ foremost vitality forex — from the wires that reach from nerves. Psilocybin did not restore the mitochondria’s total energy-producing capability. As a substitute, it preserved their capacity to journey and maintained their regular ranges of ATP manufacturing, particularly inside the nerve projections. That means the drug might assist preserve vitality provides the place they’re wanted most.
The impact trusted the serotonin receptor 5-HT2A, which is accountable for a lot of psilocybin’s psychedelic results as nicely. Intriguingly, a compound known as TBG — designed to activate 5-HT2A with out inflicting hallucinations — additionally protected mice from neuropathy.
Nonetheless, Amit cautioned that psilocybin’s psychedelic results might also be enjoying a neuroprotective function that we’ve but to grasp, so it is unclear if the impact needs to be prevented in people.
Chemotherapy can have a variety of negative effects, together with nerve harm.
(Picture credit score: Fly View Productions through Getty Photographs)
A great distance from sufferers
Strouse famous that mitochondrial damage in CIPN is not a brand new concept. “What’s novel is taking a look at psilocybin as a protectant,” he mentioned.
He additionally cautioned that completely different chemotherapy medicine might trigger neuropathy via distinct mechanisms, so the safety demonstrated towards one chemotherapy drug might not translate broadly.
Most significantly, the researchers haven’t proven that psilocybin prevents neuropathy in people but.
“The principle factor is that it was by no means examined for this indication particularly in a scientific manner in people,” Amit mentioned. His workforce is now making ready a medical trial at MD Anderson to check the strategy. The analysis is a part of MD Anderson’s Cancer Neuroscience Program, a multidisciplinary effort that research interactions between most cancers and the nervous system, with an emphasis on enhancing sufferers’ high quality of life.
Human trials might want to set up each the effectiveness and security of utilizing psilocybin for this function, Strouse mentioned, significantly earlier than oncologists would take into account giving a psychedelic drug alongside most cancers therapy.
This text is for informational functions solely and isn’t meant to supply medical recommendation.
Heles, M., Pasvolsky, L., Sathishkumar, H., Naara, S., Vu, Y., Stewart, C. L., Xie, T., Gleber-Netto, F. O., McCarthy, W., Yaniv, D., Kamal, S. S., Elahi, H., Zhu, P., Uhelski, M. L., Chatwin, J., Lara, A., Stolley, D. L., Migden, M. R., Lee, Z.-H., … Amit, M. (2026). Psilocybin prevents chemotherapy-induced peripheral neuropathy via mitochondrial trafficking preservation. Science, 393(6815). https://doi.org/10.1126/science.aec6116
